Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits

BACKGROUND: The key pathological signature of ALS/ FTLD is the mis-localization of endogenous TDP-43 from the nucleus to the cytoplasm. However, TDP-43 gain of function in the cytoplasm is still poorly understood since TDP-43 animal models recapitulating mis-localization of endogenous TDP-43 from th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hu, Yiying (VerfasserIn) , Hruscha, Alexander (VerfasserIn) , Pan, Chenchen (VerfasserIn) , Schifferer, Martina (VerfasserIn) , Schmidt, Michael K. (VerfasserIn) , Nuscher, Brigitte (VerfasserIn) , Giera, Martin (VerfasserIn) , Kostidis, Sarantos (VerfasserIn) , Burhan, Özge (VerfasserIn) , van Bebber, Frauke (VerfasserIn) , Edbauer, Dieter (VerfasserIn) , Arzberger, Thomas (VerfasserIn) , Haass, Christian (VerfasserIn) , Schmid, Bettina (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 20 June 2024
In: Molecular neurodegeneration
Year: 2024, Jahrgang: 19, Heft: 1, Pages: 1-23
ISSN:1750-1326
DOI:10.1186/s13024-024-00735-7
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13024-024-00735-7
Volltext
Verfasserangaben:Yiying Hu, Alexander Hruscha, Chenchen Pan, Martina Schifferer, Michael K. Schmidt, Brigitte Nuscher, Martin Giera, Sarantos Kostidis, Özge Burhan, Frauke van Bebber, Dieter Edbauer, Thomas Arzberger, Christian Haass and Bettina Schmid

MARC

LEADER 00000caa a2200000 c 4500
001 191720860X
003 DE-627
005 20250716231837.0
007 cr uuu---uuuuu
008 250213s2024 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13024-024-00735-7  |2 doi 
035 |a (DE-627)191720860X 
035 |a (DE-599)KXP191720860X 
035 |a (OCoLC)1528019062 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hu, Yiying  |e VerfasserIn  |0 (DE-588)1339955172  |0 (DE-627)1899471065  |4 aut 
245 1 0 |a Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits  |c Yiying Hu, Alexander Hruscha, Chenchen Pan, Martina Schifferer, Michael K. Schmidt, Brigitte Nuscher, Martin Giera, Sarantos Kostidis, Özge Burhan, Frauke van Bebber, Dieter Edbauer, Thomas Arzberger, Christian Haass and Bettina Schmid 
264 1 |c 20 June 2024 
300 |b Illustrationen 
300 |a 23 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.02.2025 
520 |a BACKGROUND: The key pathological signature of ALS/ FTLD is the mis-localization of endogenous TDP-43 from the nucleus to the cytoplasm. However, TDP-43 gain of function in the cytoplasm is still poorly understood since TDP-43 animal models recapitulating mis-localization of endogenous TDP-43 from the nucleus to the cytoplasm are missing. - METHODS: CRISPR/Cas9 technology was used to generate a zebrafish line (called CytoTDP), that mis-locates endogenous TDP-43 from the nucleus to the cytoplasm. Phenotypic characterization of motor neurons and the neuromuscular junction was performed by immunostaining, microglia were immunohistochemically localized by whole-mount tissue clearing and muscle ultrastructure was analyzed by scanning electron microscopy. Behavior was investigated by video tracking and quantitative analysis of swimming parameters. RNA sequencing was used to identify mis-regulated pathways with validation by molecular analysis. - RESULTS: CytoTDP fish have early larval phenotypes resembling clinical features of ALS such as progressive motor defects, neurodegeneration and muscle atrophy. Taking advantage of zebrafish's embryonic development that solely relys on yolk usage until 5 days post fertilization, we demonstrated that microglia proliferation and activation in the hypothalamus is independent from food intake. By comparing CytoTDP to a previously generated TDP-43 knockout line, transcriptomic analyses revealed that mis-localization of endogenous TDP-43, rather than TDP-43 nuclear loss of function, leads to early onset metabolic dysfunction. - CONCLUSIONS: The new TDP-43 model mimics the ALS/FTLD hallmark of progressive motor dysfunction. Our results suggest that functional deficits of the hypothalamus, the metabolic regulatory center, might be the primary cause of weight loss in ALS patients. Cytoplasmic gain of function of endogenous TDP-43 leads to metabolic dysfunction in vivo that are reminiscent of early ALS clinical non-motor metabolic alterations. Thus, the CytoTDP zebrafish model offers a unique opportunity to identify mis-regulated targets for therapeutic intervention early in disease progression. 
650 4 |a ALS 
650 4 |a Amyotrophic Lateral Sclerosis 
650 4 |a Animal model 
650 4 |a Animals 
650 4 |a Animals, Genetically Modified 
650 4 |a Disease Models, Animal 
650 4 |a DNA-Binding Proteins 
650 4 |a Hypothalamus 
650 4 |a Metabolic dysfunction 
650 4 |a Motor Neurons 
650 4 |a Neurodegeneration 
650 4 |a Neuromuscular Junction 
650 4 |a TDP-43 
650 4 |a Zebrafish 
650 4 |a Zebrafish Proteins 
700 1 |a Hruscha, Alexander  |e VerfasserIn  |4 aut 
700 1 |a Pan, Chenchen  |d 1987-  |e VerfasserIn  |0 (DE-588)1196384576  |0 (DE-627)1678165425  |4 aut 
700 1 |a Schifferer, Martina  |e VerfasserIn  |4 aut 
700 1 |a Schmidt, Michael K.  |e VerfasserIn  |4 aut 
700 1 |a Nuscher, Brigitte  |e VerfasserIn  |4 aut 
700 1 |a Giera, Martin  |e VerfasserIn  |4 aut 
700 1 |a Kostidis, Sarantos  |e VerfasserIn  |4 aut 
700 1 |a Burhan, Özge  |e VerfasserIn  |4 aut 
700 1 |a van Bebber, Frauke  |e VerfasserIn  |4 aut 
700 1 |a Edbauer, Dieter  |e VerfasserIn  |4 aut 
700 1 |a Arzberger, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Haass, Christian  |e VerfasserIn  |4 aut 
700 1 |a Schmid, Bettina  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Molecular neurodegeneration  |d London : Biomed Central, 2006  |g 19(2024), 1 vom: Juni, Artikel-ID 50, Seite 1-23  |h Online-Ressource  |w (DE-627)515978361  |w (DE-600)2244557-2  |w (DE-576)260614165  |x 1750-1326  |7 nnas  |a Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits 
773 1 8 |g volume:19  |g year:2024  |g number:1  |g month:06  |g elocationid:50  |g pages:1-23  |g extent:23  |a Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits 
856 4 0 |u https://doi.org/10.1186/s13024-024-00735-7  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250213 
993 |a Article 
994 |a 2024 
998 |g 1196384576  |a Pan, Chenchen  |m 1196384576:Pan, Chenchen  |p 3 
999 |a KXP-PPN191720860X  |e 4663968309 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits","title":"Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits"}],"person":[{"roleDisplay":"VerfasserIn","display":"Hu, Yiying","role":"aut","family":"Hu","given":"Yiying"},{"given":"Alexander","family":"Hruscha","role":"aut","roleDisplay":"VerfasserIn","display":"Hruscha, Alexander"},{"family":"Pan","given":"Chenchen","display":"Pan, Chenchen","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Schifferer, Martina","roleDisplay":"VerfasserIn","role":"aut","family":"Schifferer","given":"Martina"},{"role":"aut","display":"Schmidt, Michael K.","roleDisplay":"VerfasserIn","given":"Michael K.","family":"Schmidt"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Nuscher, Brigitte","given":"Brigitte","family":"Nuscher"},{"display":"Giera, Martin","roleDisplay":"VerfasserIn","role":"aut","family":"Giera","given":"Martin"},{"roleDisplay":"VerfasserIn","display":"Kostidis, Sarantos","role":"aut","family":"Kostidis","given":"Sarantos"},{"display":"Burhan, Özge","roleDisplay":"VerfasserIn","role":"aut","family":"Burhan","given":"Özge"},{"given":"Frauke","family":"van Bebber","role":"aut","display":"van Bebber, Frauke","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Edbauer, Dieter","given":"Dieter","family":"Edbauer"},{"family":"Arzberger","given":"Thomas","roleDisplay":"VerfasserIn","display":"Arzberger, Thomas","role":"aut"},{"given":"Christian","family":"Haass","role":"aut","display":"Haass, Christian","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Schmid, Bettina","role":"aut","family":"Schmid","given":"Bettina"}],"recId":"191720860X","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 13.02.2025"],"id":{"eki":["191720860X"],"doi":["10.1186/s13024-024-00735-7"]},"origin":[{"dateIssuedDisp":"20 June 2024","dateIssuedKey":"2024"}],"name":{"displayForm":["Yiying Hu, Alexander Hruscha, Chenchen Pan, Martina Schifferer, Michael K. Schmidt, Brigitte Nuscher, Martin Giera, Sarantos Kostidis, Özge Burhan, Frauke van Bebber, Dieter Edbauer, Thomas Arzberger, Christian Haass and Bettina Schmid"]},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 22.07.2019"],"disp":"Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficitsMolecular neurodegeneration","recId":"515978361","language":["eng"],"pubHistory":["1.2006 -"],"part":{"extent":"23","text":"19(2024), 1 vom: Juni, Artikel-ID 50, Seite 1-23","volume":"19","pages":"1-23","issue":"1","year":"2024"},"title":[{"title_sort":"Molecular neurodegeneration","title":"Molecular neurodegeneration"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2006-","dateIssuedKey":"2006","publisher":"Biomed Central","publisherPlace":"London"}],"id":{"issn":["1750-1326"],"eki":["515978361"],"zdb":["2244557-2"]}}],"physDesc":[{"extent":"23 S.","noteIll":"Illustrationen"}]} 
SRT |a HUYIYINGHRMISLOCALIZ2020